09.02.2013 Views

2009 Form 990-PF - Bill & Melinda Gates Foundation

2009 Form 990-PF - Bill & Melinda Gates Foundation

2009 Form 990-PF - Bill & Melinda Gates Foundation

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

BILL & MELINDA GATES FOUNDATION 56-2618866<br />

FORM <strong>990</strong><strong>PF</strong>, PART XV - GRANTS AND CONTRIBUTIONS PAID DURING THE YEAR<br />

RELATIONSHIP TO SUBSTANTIAL CONTRIBUTOR<br />

AND<br />

ATTACHMENT 18 (CONT'D)<br />

RECIPIENT NAME AND ADDRESS FOUNDATION STATUS OF RECIPIENT PURPOSE OF GRANT OR CONTRIBUTION AMOUNT<br />

LV 1 FACULTY BLDG S KENSINGTON CAMP SW72AZ FOREIGN GOVERNMENT<br />

LONDON<br />

UNITED KINGDOM<br />

PATHOGENS IN THE GUT.<br />

IMPERIAL COLLEGE LONDON NONE MATTHEW FUCHTER AND COLLABORATORS AT IMPERIAL<br />

100,000.<br />

LV 1 FACULTY BLDG S KENSINGTON CAMP SW72AZ FOREIGN GOVERNMENT<br />

LONDON<br />

UNITED KINGDOM<br />

COLLEGE LONDON IN THE UNITED KINGDOM PROPOSES<br />

TO TEST WHETHER A NOVEL CHEMICAL PRODUCED IN<br />

SOME FUNGUS SPECIES CAN CONTROL ENZYMES THAT<br />

CONTROL IMMUNE ESCAPE MECHANISMS IN MALARIA<br />

PARASITES. IF SUCCESSFUL, THIS APPROACH MAY<br />

NOT ONLY FORCE THE PARASITE TO PRESENT MANY<br />

SURFACE PROTEINS THAT ARE NORMALLY ABSENT AND<br />

STIMULATE A POWERFUL IMMUNE RESPONSE, BUT<br />

COULD ALSO DIRECTLY KILL MALARIA PARASITES.<br />

IMPERIAL COLLEGE LONDON NONE TO SUPPORT DEVELOPMENT, IMPLEMENTATION AND<br />

2,243,679.<br />

LV 1 FACULTY BLDG S KENSINGTON CAMP SW72AZ FOREIGN GOVERNMENT<br />

LONDON<br />

UNITED KINGDOM<br />

EVALUATION OF AN INTEGRATED HEALTH PACKAGE FOR<br />

POOR POPULATIONS IN BURKINA FASO, NIGER, AND<br />

IMPERIAL COLLEGE LONDON NONE TO IDENTIFY THE MOLECULAR SIGNATURES OF LATENT<br />

1,114,029.<br />

LV 1 FACULTY BLDG S KENSINGTON CAMP SW72AZ FOREIGN GOVERNMENT<br />

LONDON<br />

UNITED KINGDOM<br />

TANZANIA<br />

TB IN HUMAN TISSUES, AND TARGET THEM WITH<br />

NOVEL DRUGS<br />

IMPERIAL COLLEGE LONDON NONE TO USE NOVEL RECOMBINANT ADENOVIRUS (AD)<br />

1,616,169.<br />

LV 1 FACULTY BLDG S KENSINGTON CAMP SW72AZ FOREIGN GOVERNMENT<br />

LONDON<br />

UNITED KINGDOM<br />

FOR PUBLIC DISCLOSURE<br />

108 OF 519<br />

VECTOR TECHNOLOGIES TO DEVELOP AN HIV VACCINE<br />

ATTACHMENT 18

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!